Using plasma samples, patients with known tumour mutations revealed increased H3K36me3 cfChIP enrichment for mutated relative to WT alleles for seven of nine genes presented with mutations, including the tumour supressor gene, TP53, and the oncogene, EGFR. Here, EGFR is linked to neoplasm.